Smart ring maker Oura has agreed to acquire Counsel Health, an AI-powered primary care startup, for $625 million in an all-cash transaction. Announced on November 10, 2026, the deal will bring together Oura’s wearable health-monitoring technology with Counsel’s medical AI platform and network of licensed physicians. The acquisition is expected to expand Oura beyond tracking sleep, activity and other health indicators into delivering personalised medical guidance and access to clinical care.
The transaction represents a major step in Oura’s strategy to connect everyday health data with healthcare services. Counsel’s platform combines conversational medical AI with human doctors who can provide clinical guidance, diagnoses, prescriptions and referrals when appropriate. Oura plans to integrate these capabilities more deeply into its application, allowing members to move from understanding changes in their health to seeking medical support. The deal is expected to close before the end of 2026, subject to customary closing conditions.
Key Takeaways
- Acquisition value: Oura will acquire Counsel Health for $625 million in cash.
- Strategic expansion: The deal takes Oura beyond wearable health tracking into AI-powered primary care.
- Medical AI: Counsel combines specialised AI agents with access to licensed, board-certified physicians.
- Founder appointment: Counsel CEO Muthu Alagappan will join Oura as chief clinical AI officer.
- Workforce: Counsel’s approximately 70 employees are expected to join Oura.
- Oura membership: The wearable company reports more than six million members worldwide.
- Three healthcare priorities: Preventive care, acute care and specialty and chronic care.
- Enterprise business: Counsel will continue serving health plans, healthcare providers, employers and other partners.
Oura Acquires Counsel Health for $625 Million
Oura has entered into a definitive agreement to acquire Counsel Health for $625 million in cash, subject to purchase price adjustments.
The transaction brings together two companies working on different parts of the healthcare experience.
Oura collects continuous biometric information through its smart ring and health platform. Counsel uses medical AI and human physicians to help patients understand health concerns and access appropriate care.
The companies already had an existing partnership, with Counsel’s AI-powered medical assistance integrated into the Oura application in June 2026.
The acquisition will allow Oura to bring the technology and clinical capabilities further into its ecosystem.
According to Oura, the transaction is expected to close before the end of calendar year 2026, subject to customary closing conditions.
The financial terms are significant for a healthcare technology acquisition. However, Oura has not disclosed a detailed breakdown of the purchase price or the financial structure beyond confirming the all-cash transaction.
What Is Counsel Health?
Counsel Health is an AI-native primary care company founded in 2023 by physician and AI researcher Muthu Alagappan.
The startup was established around a problem facing healthcare systems: patients often struggle to access medical advice quickly because of appointment delays, physician shortages and rising healthcare costs.
Counsel developed a platform that combines medical artificial intelligence with in-house physicians.
Instead of requiring patients to begin with a conventional appointment, the service allows them to start a conversation with its medical AI.
The system can collect information about symptoms, review medical records and provide guidance based on clinical information.
When a situation requires human medical judgment, patients can connect with a physician.
The company says its service can support a wide range of healthcare needs, including:
- Everyday medical questions.
- Initial assessment of symptoms.
- Prescription-related consultations.
- Review of laboratory results.
- Referrals to specialists.
- Support for chronic health conditions.
- Preventive healthcare guidance.
Counsel’s model is designed to make medical assistance more accessible while retaining human physicians for clinical decisions.
The company says it has made its services available to more than eight million Americans through enterprise partnerships.
How Counsel’s Medical AI Works
Counsel’s technology is not simply a general-purpose chatbot answering health questions.
The company has developed a clinical AI system that uses specialised agents for different medical tasks.
According to its announcement, these agents can perform activities such as:
| AI capability | Function |
|---|---|
| Medical history-taking | Collects relevant information about a patient’s health |
| Clinical guideline retrieval | Retrieves relevant medical guidance |
| Medical records review | Examines available patient records |
| Emergency detection | Identifies potential situations requiring urgent attention |
| Clinical support | Organises information for physician review |
These agents operate within a clinical system designed to evaluate performance, safety and quality.
Patients can begin by interacting with Counsel’s AI, which draws on connected medical records, previous conversations, evidence-based clinical guidelines and available health information.
If additional clinical judgment is needed, the patient can request a consultation with a Counsel physician.
The company says its physicians can provide diagnoses, prescriptions and referrals where appropriate.
Counsel also has a proprietary tool called Clinician Cockpit, which helps doctors review patient records and longer-term health trends during consultations.
The aim is to combine the speed of AI with the judgment and accountability of qualified medical professionals.
How Oura Ring Data Could Improve AI-Powered Healthcare
The acquisition is particularly important because Oura already collects continuous biometric information through its smart ring.
The device tracks several health-related measurements, including:
- Heart rate.
- Heart-rate variability.
- Sleep patterns.
- Body temperature trends.
- Activity levels.
- Respiratory rate.
- Recovery indicators.
- Stress-related measurements.
These signals can help users understand changes in their daily health patterns.
However, wearable information is often disconnected from the healthcare system.
A person may notice changes in sleep, resting heart rate or other measurements but still need a healthcare professional to understand what those changes mean.
Oura wants to connect its wearable data with Counsel’s clinical platform.
For example, a user noticing a sustained change in a health metric could begin a conversation with Counsel through the Oura application.
The AI could consider available biometric trends alongside symptoms and medical history. If necessary, the user could then connect with a physician.
This creates a potential link between everyday health monitoring and medical care.
Importantly, wearable measurements are not medical diagnoses. Oura says its ring is not a medical device and is not intended to diagnose, treat, cure, monitor or prevent medical conditions.
Clinical decisions must still be made through appropriate medical evaluation.
Oura Plans to Expand Across Three Healthcare Areas
The companies have identified three major areas where they intend to develop their combined healthcare platform.
1. Preventive Healthcare
Preventive healthcare focuses on identifying potential health changes and helping people take action before problems become more serious.
Oura already collects continuous health information through its wearable devices.
By combining this information with Counsel’s medical AI and physician access, the companies want to provide more personalised guidance.
For example, changes in a person’s sleep or other biometric trends could become a starting point for a healthcare conversation.
The objective is to shorten the time between noticing a change and obtaining relevant medical advice.
However, wearable trends alone cannot establish that someone has a medical condition.
2. Acute Healthcare
Acute care involves medical concerns that arise suddenly and require timely attention.
Counsel’s AI platform can help users discuss symptoms and determine what type of medical support may be appropriate.
If necessary, the patient can be connected to an in-house physician.
This could make it easier to obtain guidance for everyday health concerns without immediately navigating a traditional appointment process.
Serious or emergency symptoms still require appropriate emergency medical services rather than relying on an AI chatbot.
3. Specialty and Chronic Care
The third area involves conditions and healthcare needs that require longer-term management.
Oura and Counsel plan to develop support across areas including:
- Reproductive health.
- Cardiometabolic health.
- Ageing-related health needs.
- Chronic disease management.
- Ongoing preventive care.
Continuous biometric information could provide additional context for physicians reviewing a patient’s health over time.
The companies believe this could help make healthcare more personalised and continuous.
Oura’s Business Is Growing Rapidly
The acquisition comes as Oura reports strong growth in its wearable health business.
In its November 10 announcement, the company reported preliminary financial results for its fiscal year 2026.
| Financial metric | Reported performance |
|---|---|
| FY2026 revenue | Approximately $1.75 billion |
| FY2026 revenue growth | 92% year-on-year |
| Q4 FY2026 revenue | $533 million |
| Q4 revenue growth | 153% year-on-year |
| Q4 adjusted EBITDA | $87 million |
| Q4 adjusted EBITDA margin | 16% |
| Global membership | More than 6 million |
These figures were provided by Oura and are preliminary and unaudited. They may change after the company’s financial closing procedures and audit.
The numbers indicate that Oura is expanding beyond its original smart-ring hardware business.
Its platform increasingly includes software, health insights, subscriptions and partnerships with healthcare organisations.
The Counsel acquisition could help it develop additional services around its existing member base.
Why the Acquisition Matters Financially
The deal could create new opportunities for Oura to generate value from its customers.
The company currently helps members monitor and understand their health.
Adding access to AI-powered medical guidance and physicians could increase the range of services available through its platform.
This may improve customer engagement and potentially increase the lifetime value of its members.
Counsel’s enterprise partnerships also provide a route to reach people who do not own an Oura Ring.
That could expand the potential market beyond the company’s existing wearable customers.
Oura’s IPO Plans and Its $625 Million Acquisition
The acquisition also comes after Oura postponed its planned initial public offering.
According to TechCrunch and Reuters, the company had been preparing for a potential IPO but delayed the process amid uncertainty in financial markets.
Oura had previously reached an approximately $11 billion valuation following a $900 million funding round in October 2025.
The decision to acquire Counsel for $625 million in cash therefore represents a major investment in expanding the company’s healthcare capabilities.
Rather than relying exclusively on hardware sales and wearable subscriptions, Oura is positioning itself as a broader health intelligence and care platform.
The strategy could make the company more attractive to investors looking at the intersection of consumer technology, healthcare services and artificial intelligence.
However, the acquisition also introduces new responsibilities involving clinical operations, medical quality, privacy and healthcare regulation.
What Happens to Counsel’s Existing Customers?
Counsel will continue serving its existing and new enterprise partners after the acquisition.
Its customers include health plans, health systems, consumer health organisations and employers.
This is an important part of the deal because Counsel’s business is not limited to individual Oura Ring owners.
The company says its enterprise services will remain available without requiring customers to purchase an Oura device.
Counsel’s founder has also said that its existing consumer application will continue to support current healthcare services during the transition.
The companies intend to expand the platform to reach millions of people beyond Oura’s existing membership.
For healthcare organisations, this could create an opportunity to use medical AI and physician-supported services without depending entirely on Oura’s wearable hardware.
What the Acquisition Means for the AI Healthcare Industry
Oura’s acquisition reflects a wider trend in healthcare technology.
Wearable companies have traditionally focused on collecting health information and helping users understand their activity, sleep and other physiological measurements.
AI healthcare startups, meanwhile, have focused on making medical information and clinical services more accessible.
Bringing these capabilities together could create a more connected healthcare experience.
| Company or technology | Primary focus |
|---|---|
| Oura | Continuous biometric monitoring and health insights |
| Counsel Health | Medical AI and physician-supported primary care |
| Combined platform | Wearable health context connected to personalised medical care |
The broader opportunity is to reduce the gap between monitoring health and receiving appropriate medical support.
However, healthcare is a highly regulated industry. Medical AI systems must be evaluated for safety, accuracy, privacy and clinical reliability.
Human physician oversight will remain important, particularly when patients need diagnoses, prescriptions or referrals.
The acquisition is therefore not simply a technology integration. It represents an expansion into a more complex healthcare business.
The Bigger Picture
Oura’s $625 million acquisition of Counsel Health highlights a growing convergence between wearable technology, artificial intelligence and clinical healthcare. Smart devices can collect continuous information about people’s health, while medical AI can help interpret information and connect users with appropriate care. By bringing these capabilities together, Oura wants to create a platform that moves beyond tracking health metrics and helps people act on them through medical guidance and physician access.
The deal could also reshape Oura’s business model by opening opportunities in preventive care, acute consultations and chronic disease management. Counsel’s existing enterprise relationships provide access to customers beyond Oura’s wearable membership, while its physician network adds a human clinical layer to the platform. The long-term opportunity is substantial, but success will depend on clinical safety, patient trust, data protection and the company’s ability to deliver reliable healthcare at scale.
Frequently Asked Questions
1. How much is Oura paying to acquire Counsel Health?
Oura has agreed to acquire Counsel Health for $625 million in cash, subject to purchase price adjustments.
2. What does Counsel Health do?
Counsel Health operates an AI-powered primary care platform that combines conversational medical AI with access to licensed physicians for medical guidance, diagnoses, prescriptions and referrals.
3. Who founded Counsel Health?
Counsel Health was founded in 2023 by Muthu Alagappan, a physician and AI researcher.
4. What will happen to Counsel Health after the acquisition?
Counsel will become part of Oura while continuing to serve its existing and new enterprise partners. Its technology will be integrated more closely with Oura’s health intelligence platform.
5. How will Oura Ring data be used by Counsel?
Oura’s biometric information can provide additional context for medical conversations, helping Counsel’s AI and physicians consider longer-term health trends alongside symptoms and medical records.
6. Will Oura users get access to doctors?
Oura and Counsel plan to expand access to AI-assisted medical guidance and physicians through the Oura application. The exact availability and scope of services may depend on the rollout and applicable healthcare arrangements.
7. How many members does Oura have?
Oura reported more than six million members worldwide in its November 2026 acquisition announcement.
8. When will the acquisition be completed?
The transaction is expected to close before the end of 2026, subject to customary closing conditions.
Looking Ahead
Oura’s next challenge will be integrating Counsel’s medical AI and physician network into its existing wearable ecosystem while maintaining clinical quality and patient trust. The company plans to expand across preventive, acute and chronic care, giving its members more ways to act on information collected by their devices. Counsel’s enterprise relationships could also help Oura reach millions of people who do not currently use its smart rings.
The acquisition represents a broader shift in the health technology industry, where wearable devices are increasingly being connected to clinical services and AI-powered decision support. Oura has built a large business around helping people understand their bodies; Counsel adds a pathway towards medical action. Whether this combination becomes a meaningful healthcare platform will depend on how effectively it connects biometric information with safe, accessible and reliable clinical care.
Get the day’s top stories in your inbox
One concise email. No spam, unsubscribe anytime.
